Repositioning Candidate Details

Candidate ID: R0687
Source ID: DB05053
Source Type: investigational
Compound Type: small molecule
Compound Name: MB-07803
Synonyms: --
Molecular Formula: C24H37N4O7PS
SMILES: CCOC(=O)C(C)(C)NP(=O)(NC(C)(C)C(=O)OCC)C1=CC=C(O1)C1=C(SC(N)=N1)C(=O)C(C)(C)C
Structure:
DrugBank Description: MB07803 is a second generation gluconeogenesis inhibitor for the treatment of type 2 diabetes. It is designed to block the metabolic pathway in the liver that is responsible for producing glucose.
CAS Number: 882757-24-6
Molecular Weight: 556.61
DrugBank Indication: Investigated for use/treatment in diabetes mellitus type 2.
DrugBank Pharmacology: --
DrugBank MoA: MB07803 is a selective inhibitor of fructose-1, 6-bisphosphatase (FBPase), a regulatory enzyme in the pathway responsible for the production of glucose in the liver, known as the gluconeogenesis pathway. By specifically inhibiting this pathway, liver glucose production should be reduced and blood sugar levels decreased in patients with diabetes, independent of insulin levels and body weight.
Targets: Fructose-1,6-bisphosphatase 1
Inclusion Criteria: Indication associated